FMS (Fresenius Medical Care AG) Stock Analysis - AI Report

Fresenius Medical Care AG (FMS) is a publicly traded Healthcare sector company. As of May 20, 2026, FMS trades at $22.21 with a market cap of $11.94B and a P/E ratio of 0.00. FMS moved +0.43% today. Year to date, FMS is -6.64%; over the trailing twelve months it is -25.63%. Its 52-week range spans $18.94 to $30.46. Analyst consensus is neutral with an average price target of $26.00. Rallies surfaces FMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on FMS?

Rallies AI research for FMS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

FMS Key Metrics

Key financial metrics for FMS
MetricValue
Price$22.21
Market Cap$11.94B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.87%
52-Week High$30.46
52-Week Low$18.94
Volume601.52K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest FMS News

FMS Analyst Consensus

1 analysts cover FMS: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $26.00.

Common questions about FMS

What is the AI research view on FMS?
Rallies AI research for FMS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for FMS?
Rallies AI research for FMS combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is FMS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FMS. It does not provide personalized investment advice.
FMS

FMS